Big Data and The Internet of Medical Things (IOMT) have long been touted as the next revolutionary force in healthcare. However, the Covid-19 pandemic and the ensuing avalanche of information have critically highlighted how difficult it remains to sift through and interpret large amounts of disparate data. Now more than ever, healthcare system stakeholders must adopt intelligent data frameworks to organize information, invest in data science, and accelerate the healthcare applications of novel AI systems.
As IOMT progresses, multi-variate “live data streaming” from integrated medical devices will be a crucial component in evidence generation. Moreover, this ability will shift from being primarily a resource for product surveillance and improvement to being a value proposition in of itself.
Properly utilized, this enormously rich data source will help healthcare providers and policy makers better deal with crises like the Covid-19 pandemic, and will be the foundation for improved evidence generation, life-saving predictive analytics, and ultimately better patient outcomes.
Join us in exploring how IQVIA envisages the future of IOMT and how MedTech companies can be a pioneering force in the next phase of Big Data analytics.